These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37692554)

  • 1. Patient perceptions of copay card utilization and policies.
    Cavalier D; Doherty B; Geonnotti G; Patel A; Peters W; Zona S; Shea L
    J Mark Access Health Policy; 2023; 11(1):2254586. PubMed ID: 37692554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of racial and ethnic inequities in copay card utilization and enrollment in copay adjustment programs.
    Ingham M; Sadik K; Zhao X; Song J; Fendrick AM
    J Manag Care Spec Pharm; 2023 Sep; 29(9):1084-1092. PubMed ID: 37548953
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of copay assistance on patient out-of-pocket costs and treatment rates with ALK inhibitors.
    Seetasith A; Wong W; Tse J; Burudpakdee C
    J Med Econ; 2019 May; 22(5):414-420. PubMed ID: 30729850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient perspectives and use of copayment assistance during the COVID-19 pandemic.
    Wong WB; Jinnett K
    J Manag Care Spec Pharm; 2023 Jan; 29(1):17-23. PubMed ID: 35481416
    [No Abstract]   [Full Text] [Related]  

  • 5. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
    Nemlekar P; Shepherd M; Lawson K; Rush S
    J Manag Care Pharm; 2013 Oct; 19(8):602-8. PubMed ID: 24074006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Legal and Practical Implications of Copay Accumulator and Maximizer Programs.
    Linehan JS
    Manag Care; 2019 Feb; 28(2):42-44. PubMed ID: 30883325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discussing patients' insurance and out-of-pocket expenses during GPs' consultations.
    Victoor A; Noordman J; Potappel A; Meijers M; Kloek CJJ; de Jong JD
    BMC Health Serv Res; 2019 Feb; 19(1):141. PubMed ID: 30819156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out-Of-Pocket Expenses? Insights From ARTEMIS.
    Rymer JA; Kaltenbach LA; Peterson ED; Cohen DJ; Fonarow GC; Choudhry NK; Henry TD; Cannon CP; Wang TY
    J Am Heart Assoc; 2022 Oct; 11(20):e026421. PubMed ID: 36250667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States.
    Chovatiya R; Begolka WS; Thibau IJ; Silverberg JI
    Dermatitis; 2022 Nov-Dec 01; 33(6S):S43-S51. PubMed ID: 34516440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing patient assistance program use and patient responsiveness to specialty drug price for multiple sclerosis in a mid-size integrated health system.
    Brouwer E; Yeung K; Barthold D; Hansen R
    J Manag Care Spec Pharm; 2021 Jun; 27(6):732-742. PubMed ID: 34057391
    [No Abstract]   [Full Text] [Related]  

  • 11. Financial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States.
    Chovatiya R; Begolka WS; Thibau IJ; Silverberg JI
    Arch Dermatol Res; 2022 Oct; 314(8):739-747. PubMed ID: 34580770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of prescription abandonment with cost share for high-cost specialty pharmacy medications.
    Gleason PP; Starner CI; Gunderson BW; Schafer JA; Sarran HS
    J Manag Care Pharm; 2009 Oct; 15(8):648-58. PubMed ID: 19803554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial Hardship After Traumatic Injury: Risk Factors and Drivers of Out-of-Pocket Health Expenses.
    O'Neill KM; Jean RA; Gross CP; Becher RD; Khera R; Elizondo JV; Nasir K
    J Surg Res; 2020 Dec; 256():1-12. PubMed ID: 32663705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost reduction strategies used by elderly patients with chronic obstructive pulmonary disease to cope with a generic-only pharmacy benefit.
    Spence MM; Hui R; Chan J
    J Manag Care Pharm; 2006 Jun; 12(5):377-82. PubMed ID: 16792444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The financial burden of out-of-pocket healthcare expenses on caregivers of children with atopic dermatitis in the United States.
    Chovatiya R; Begolka WS; Thibau IJ; Silverberg JI
    Skin Health Dis; 2023 Feb; 3(1):e191. PubMed ID: 36751334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the Medicare modernization act on low-income persons.
    Havrda DE; Omundsen BA; Bender W; Kirkpatrick MA
    Ann Intern Med; 2005 Oct; 143(8):600-8. PubMed ID: 16230727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does a One-Size-Fits-All Cost-Sharing Approach Incentivize Appropriate Medication Use? A Roundtable on the Fairness and Ethics Associated with Variable Cost Sharing.
    Graff JS; Shih C; Barker T; Dieguez G; Larson C; Sherman H; Dubois RW
    J Manag Care Spec Pharm; 2017 Jun; 23(6):621-627. PubMed ID: 28530519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atopic Dermatitis Polypharmacy and Out-Of-Pocket Healthcare Expenses.
    Chovatiya R; Smith Begolka W; Thibau I; Silverberg J
    J Drugs Dermatol; 2023 Feb; 22(2):154-164. PubMed ID: 36745366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A copay foundation assistance support program for patients receiving intravenous cancer therapy.
    Rajurkar SP; Presant CA; Bosserman LD; McNatt WJ
    J Oncol Pract; 2011 Mar; 7(2):100-2. PubMed ID: 21731517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of brand drug discount cards on private insurer, government and patient expenditures.
    Law MR; Chan FKI; Harrison M; Worthington HC
    CMAJ; 2019 Nov; 191(45):E1237-E1241. PubMed ID: 31712357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.